Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biotage AB's share price for the quarter that ended in Sep. 2024 was $18.52. Biotage AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 80.0 Mil. Therefore, Biotage AB's market cap for the quarter that ended in Sep. 2024 was $1,482.5 Mil.
Biotage AB's quarterly market cap
declined
from Mar. 2024 ($1,349.7 Mil) to Jun. 2024 ($1,255.3 Mil) but then
increased
from Jun. 2024 ($1,255.3 Mil) to Sep. 2024 ($1,482.5 Mil).
Biotage AB's annual market cap
declined
from Dec. 2021 ($1,942.2 Mil) to Dec. 2022 ($1,121.7 Mil) and
declined
from Dec. 2022 ($1,121.7 Mil) to Dec. 2023 ($960.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biotage AB's Enterprise Value for Today is $1,179.9 Mil.
Biotage AB Market Cap Historical Data
The historical data trend for Biotage AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Biotage AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotage AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Biotage AB's Market Cap falls into.
Biotage AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Biotage AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotage AB (OTCPK:BITGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Biotage AB Market Cap Related Terms
Thank you for viewing the detailed overview of Biotage AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BITGF has been successfully added to your 